Australian, English Researchers Find CBD, Chemotherapy Treatment Slows Pancreatic Cancer in Mice

Australian, English Researchers Find Cbd, Chemotherapy Treatment Slows Pancreatic Cancer In Mice

Share Tweet Share PinFor decades, a diagnosis of pancreatic cancer has been a death sentence — even remission rates are dismal. However, a study in July 2018 in Oncogene, a peer-reviewed journal published by Nature Publishing Group, reveals some promising research involving cannabidiol (CBD) therapy. The grim prognoses could soon change, said lead researcher on the study, Dr. Marco Falasca, a professor in the School of Pharmacy & Biomedical Sciences at Curtin University in Perth, Australia. The first paragraph of the study laid out the sad reality of pancreatic cancer treatment: “The life expectancy for pancreatic cancer patients has seen no substantial changes in the last 40 years as very few and mostly just palliative treatments are available. As the five years’ survival rate remains around 5 percent, the identification of novel pharmacological targets and development of new therapeutic strategies are urgently needed.” Falasca and his colleagues at Queen Mary University in...



See Article on Marijuana.com HERE